EcoDrugPlus

Mapk Activated Protein Kinase 2

Ensembl ID : ENSLACG00000006226
Gene Symbol: MAPKAPK2
4 Cross references
235 Possible Orthologues:

Mapk Activated Protein Kinase 5

Ensembl ID : ENSLACG00000011061
Gene Symbol: MAPKAPK5
4 Cross references
179 Possible Orthologues:

Mapk Interacting Serine/threonine Kinase 2

Ensembl ID : ENSLACG00000011530
Gene Symbol: MKNK2
2 Cross references
224 Possible Orthologues:

Mcl1 Apoptosis Regulator, Bcl2 Family Member

Ensembl ID : ENSLACG00000010643
Gene Symbol: MCL1
4 Cross references
240 Possible Orthologues:

Mdm2 Proto-Oncogene

Ensembl ID : ENSLACG00000010207
Gene Symbol: MDM2
4 Cross references
282 Possible Orthologues:

Met Proto-Oncogene, Receptor Tyrosine Kinase

Ensembl ID : ENSLACG00000013435
Gene Symbol: MET
4 Cross references
212 Possible Orthologues:

Mtor Associated Protein, Lst8 Homolog

Ensembl ID : ENSLACG00000016585
Gene Symbol: MLST8
4 Cross references
202 Possible Orthologues:

N-Acetylated Alpha-Linked Acidic Dipeptidase 2

Ensembl ID : ENSLACG00000012437
Gene Symbol: NAALAD2
4 Cross references
340 Possible Orthologues:

Nad(P)h Quinone Dehydrogenase 1

Ensembl ID : ENSLACG00000008094
Gene Symbol: NQO1
4 Cross references
195 Possible Orthologues:

Nadph Oxidase 4

Ensembl ID : ENSLACG00000010409
Gene Symbol: NOX4
2 Cross references
151 Possible Orthologues:

Nfe2 Like Bzip Transcription Factor 2

Ensembl ID : ENSLACG00000008795
Gene Symbol: NFE2L2
4 Cross references
216 Possible Orthologues:

Npc1 Like Intracellular Cholesterol Transporter 1

Ensembl ID : ENSLACG00000022620
Gene Symbol: NPC1L1
4 Cross references
189 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).